0001140361-18-043570.txt : 20181121 0001140361-18-043570.hdr.sgml : 20181121 20181121161752 ACCESSION NUMBER: 0001140361-18-043570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181119 FILED AS OF DATE: 20181121 DATE AS OF CHANGE: 20181121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DSM International B.V. CENTRAL INDEX KEY: 0001706502 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 181198389 BUSINESS ADDRESS: STREET 1: HET OVERLOON 1 CITY: HEERLEN STATE: P7 ZIP: 6411 TE BUSINESS PHONE: 31-455782870 MAIL ADDRESS: STREET 1: HET OVERLOON 1 CITY: HEERLEN STATE: P7 ZIP: 6411 TE REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koninklijke DSM N.V. CENTRAL INDEX KEY: 0001121615 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34885 FILM NUMBER: 181198390 BUSINESS ADDRESS: STREET 1: HET OVERLOON 1 HEERLEN STREET 2: PO BOX 6401 JH HEERLEN CITY: NETHERLANDS STATE: P7 ZIP: - BUSINESS PHONE: 2122252142 MAIL ADDRESS: STREET 1: HET OVERLOON 1 HEERLEN STREET 2: PO BOX 6401 JH HEERLEN CITY: NETHERLANDS STATE: P7 ZIP: - FORMER NAME: FORMER CONFORMED NAME: DSM NV DATE OF NAME CHANGE: 20000809 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYRIS, INC. CENTRAL INDEX KEY: 0001365916 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 550856151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-0761 MAIL ADDRESS: STREET 1: 5885 HOLLIS STREET, SUITE 100 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: AMYRIS BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060613 4 1 form4.xml FORM 4 X0306 4 2018-11-19 0001365916 AMYRIS, INC. AMRS 0001706502 DSM International B.V. HET OVERLOON 1 HEERLEN P7 6411 TE NETHERLANDS true true 0001121615 Koninklijke DSM N.V. HET OVERLOON 1 HEERLEN P7 6411 TE NETHERLANDS true true Common Stock 2018-11-19 4 A 0 1643991 A 10328951 I See footnote Common Stock 2018-11-19 4 X 0 964837 0.0015 A 11293788 I See footnote Common Stock 2018-11-19 4 X 0 1713565 0.0001 A 13007353 I See footnote Warrants (right to buy) 0.0015 2018-11-19 4 J 0 964837 0 A 2018-11-19 2022-07-10 Common Stock 964837 964837 I See footnote Warrants (right to buy) 0.0001 2018-11-19 4 J 0 1713565 0 A 2018-11-19 2023-05-23 Common Stock 1713565 1713565 I See footnote Warrants (right to buy) 0.0015 2018-11-19 4 X 0 964837 0 D 2018-11-19 2022-07-10 Common Stock 964837 0 I See footnote Warrants (right to buy) 0.0001 2018-11-19 4 X 0 1713565 0 D 2018-11-19 2023-05-23 Common Stock 1713565 0 I See footnote In consideration of certain agreements of affiliates of the Reporting Persons set forth in a commercial agreement entered into with the Issuer on November 19, 2018, the Issuer's board of directors approved the issuance of the shares reported herein. The securities reported herein are held of record by DSM International B.V., which is a wholly owned subsidiary of Koninklijke DSM N.V. Accordingly, Koninklijke DSM N.V. may be deemed to share beneficial ownership of the securities held of record by DSM International B.V. Koninklijke DSM N.V. is a publicly traded company with securities listed on the Amsterdam Stock Exchange. In connection with an investment in the Issuer by a third party on August 3, 2017, as agreed by DSM International B.V. and the Issuer on November 19, 2018, the anti-dilution provisions of the Warrants were triggered, resulting in the Warrants becoming exercisable for 964,837 shares of Common Stock at an exercise price of $0.0015 per share, which Warrants were exercised by the Reporting Persons on November 19, 2018. In connection with amendments to existing securities of the Issuer held by a third party on August 17, 2018, as agreed by DSM International B.V. and the Issuer on November 19, 2018, the anti-dilution provisions of the Warrants were triggered, resulting in the Warrants becoming exercisable for 1,713,565 shares of Common Stock at an exercise price of $0.0001 per share, which Warrants were exercised by the Reporting Persons on November 19, 2018. DSM International B.V. By: /s/ Hugh Welsh, President, DSM North America 2018-11-21 Koninklijke DSM N.V. By: /s/ Hugh Welsh, President, DSM North America 2018-11-21